Time filter

Source Type

Petah Tikva, Israel

Can Fite Biopharma Ltd. | Date: 2014-08-21

The present application provides methods and compositions for inducing hepatocyte proliferation and liver regeneration, the latter being mainly dependent on hepatocyte proliferation even if all the other cell types divide to reconstitute the organ specific-lobular-architecture. The methods and compositions provided herein make use of an A

Can Fite Biopharma Ltd. | Date: 2010-05-16

The present disclosure provides the use of an A3R agonist, such as IB-MECA, for reducing in a subject, preferably, human subject, intra ocular pressure (IOP). Similarly, the invention provides a pharmaceutical composition and a method for reducing IOP in a subject making use of the A

Can Fite Biopharma Ltd. | Date: 2013-08-22

Inflammatory state in a subject is assayed by determining the level of expression of A

Can Fite Biopharma Ltd. | Date: 2010-05-06

The present invention provides a method for treating dry eye condition in an individual comprising administrating to said individual an amount of A

The present invention is based on the clinical finding that twice daily administrations of 2 mg of 1-[N

Discover hidden collaborations